GTC is hiring for several positions including Molecular CLS, hematopathologist, Molecular QA Manager, and more. Please note we are only considering domestic candidates who are willing to work onsite. Check out our careers page for more info: https://lnkd.in/d7dyafk #CLS #Pathology #Hiring
Genomic Testing Cooperative
Biotechnology Research
Lake Forest, California 2,746 followers
Making Genomics Available and Affordable for Everyone
About us
Our Mission is to create a diagnostic service that provides access to advanced genomic testing in communities everywhere. Our testing provides answers for ALL cancers covering both solid tumors and hematologic neoplasms. Genomic Testing Cooperative (GTC) is a different kind of cancer diagnostic laboratory. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. In creating a network of Co-Op partners, we help get results to physicians faster, share knowledge and generate better outcomes for patients.
- Website
-
https://genomictestingcooperative.com
External link for Genomic Testing Cooperative
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Lake Forest, California
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Genomic testing, Precision Medicine, Next Gen Sequencing, Oncology, Hematology, Comprehensive Genomic Profiling, Leukemia, Lymphoma, Myeloma, Lung Cancer, Breast Cancer, Colon Cancer, and CDx
Locations
-
Primary
25371 Commercentre Dr
Lake Forest, California 92630, US
Employees at Genomic Testing Cooperative
-
Jeffrey Owen
Vice President, Marketing @ Genomic Testing Cooperative
-
Rachel Rosenberger
Lead Clinical Data Reporter at Genomic Testing Cooperative
-
Maher Albitar
Founder, Chief Executive Officer and Chief Medical Officer at Genomic Testing Cooperative
-
Jennifer Varca
Vice President, Business Development
Updates
-
GTC's AI software is bespoke for our workflows delivering the highest quality results. We have developed multiple types of software to evaluate a multitude of genomic functions including TMB, clonality, fusions and more. Whether you are asking us to sign out your cases or want to internalize our NGS tests we make it easy for any pathologist to analyze and interpret NGS results. Learn more: https://lnkd.in/dxetS5hV #Pathology #NGS #AI
-
GTC's Solid Tumor profile plus provides clinically actionable data including: -CNV's -Amplifications -MSI/TMB -Viral HPV, EBV and TTV -HLA Genotyping -Gene expression -Fusions/translocations -Deletions/Duplications Exon skipping/Alternative splicing and more https://lnkd.in/d8NzX7b #RNA #DNA #Geneexpression
-
One of the unique features of GTC's Liquid Trace assay is that it can be highly sensitive when a tissue biopsy for baseline testing isn't available and still offer the broad coverage benefits of comprehensive genomic profiling. https://lnkd.in/eEUyiVEx #Tumorinformed #Tumoragnostic #cfRNA
-
GTC's Liquid Trace reports now include a graphic presentation of the detected mutations as quantified per 1 mL of plasma or CSF. Learn more: https://lnkd.in/duiFUP8F #CSF #Liquidbiopsy #cfRNA
-
GTC will be exhibiting at the SNO/ASCO CNS metastases conference in Denver, CO August 8-10. We will be showcasing our Liquid Trace assay which can use CSF as a specimen. Learn more: https://lnkd.in/duiFUP8F #CNS #CSF #Neurooncology
-
GTC's franchising model is a turn key solution that is easier than alternative options. Offering everything you need to build a lab, validate an assay, commercialize and get reimbursement. This includes: -Equipment lists -SOP's -Training -Reimbursement support -IT -Marketing -and more https://lnkd.in/g4EeP-j #NGS #RNA #DNA
-
Today we bring awareness to patients who suffer from glioblastoma, which is the deadliest form of brain cancer. There are treatment options for glioblastoma that are biomarker driven. GTC's Liquid Trace assay can help physicians and patients better understand the biology of glioblastoma via blood or a CSF sample when tissue is not available giving them a chance to identify an actionable biomarker. Learn more: https://lnkd.in/dzTPmezC #GBMday #Glioblastoma #CSF
-
GTC offers a wider variety of tests and specimen types to help consolidate your lab send outs or for use in your own laboratory if you are looking to internalize testing. Learn more: https://lnkd.in/d-jytxwT #CSF #Bonemarrow #FFPE #skinbiopsy
-
According to a recent article in the Journal of Clinical Oncology (JCO) Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care sheds some light on what QNS rates are across labs nationally. The article stated inconclusive results due to technical failure are 7.5%, QNS results are 5.8% and inconclusive data is 1.1%. GTC has one of the lowest QNS at 0.4% and very limited technical failure rates, even though we start with as little as 6 slides for DNA and RNA analysis Learn more – link to: specimen page - https://lnkd.in/d-jytxwT